HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
EPS (Diluted)
HLS Therapeutics Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
EPS (Diluted)
$0
|
CAGR 3-Years
-21%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-29%
|
See Also
What is HLS Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-0.9
USD
Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's EPS (Diluted) amounts to -0.9 USD.
What is HLS Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
2%
Over the last year, the EPS (Diluted) growth was -16%. The average annual EPS (Diluted) growth rates for HLS Therapeutics Inc have been -21% over the past three years , 2% over the past five years .